Clinical Trial Update: Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic comparison of efanesoctocog alfa versus other extended-half-life recombinant FVIII products in participants with severe hemophilia A; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Efanesoctocog alfa (efanesoctocog alfa)
• Other extended-half-life recombinant FVIII products (comparators)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Hemophilia A | Phase 1 | Status: RECRUITING